Davida Eichenbaum News Today

The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.

In the PULSAR study, White and Asian participants had similar best corrected visual acuity improvements in the 2 mg aflibercept group.

This week's topics include the importance of the 2024 election, common vision problems, more debate on the stadium project and recreational marijuana.

Here are the best blue-light blocking glasses you can buy in 2022. Our experts are also revealing if they really work.

It's time again to check the pulse — of Florida's health care policy and politics.